Updated October 7, 2026 · By Rob Braddock
Value stream mapping for specialty chemical manufacturing helps explain why a batch takes much longer to reach the customer than it spends in processing. Materials may wait for equipment, samples may queue for testing, and finished goods may wait for review or dispatch. Improving one reactor will not resolve every delay across that journey.
Use this practical guide to select a product family, collect useful data, and turn the findings into an improvement plan. The worked example is illustrative and does not represent a client result.
What Is Value Stream Mapping?
The Lean Enterprise Institute describes value stream mapping as examining material and information flows from order to delivery. A current state map records actual conditions. A future state map describes the intended flow after improvements.
For batch chemical operations, include scheduling decisions, material status, processing, testing, review, and shipping. Keep required quality and safety controls visible. A long duration is a reason to investigate, not proof that an activity can be removed.
Choose a Product Family and a Clear Boundary
Start with products that share a meaningful process route and similar constraints. Mixing every formulation into one average can hide important differences in reaction time, cleaning requirements, testing, and packaging. Choose a recurring delivery problem and define the start and finish points before collecting data.
- State the customer need, such as reliable delivery of a recurring product family.
- Decide whether the scope runs from order acceptance, material receipt, or another defined event.
- Include production, planning, quality, warehouse, maintenance, and purchasing representatives.
- Assign one person to own the map and the resulting action plan.
Collect Data from the Actual Batch Journey
| Data to collect | What it reveals |
|---|---|
| Batch and product family | Whether comparisons cover similar work. |
| Arrival, start, and finish timestamps | Processing time and waiting time at each stage. |
| Queue size and material status | Where batches accumulate or cannot proceed. |
| Equipment occupancy and changeovers | Which shared assets limit flow. |
| Sample submission, testing, and review times | Laboratory and decision handoff delays. |
| Rework, interruptions, and missing information | Recurring exceptions that increase lead time. |
| Scheduling and priority decisions | How instructions reach each team. |
Use observed work and traceable records. Review typical batches and difficult ones. Distinguish elapsed time from labor hours and equipment occupancy. A reactor can be occupied during a hold even when no operator is actively working. Record parallel activities separately to avoid overstating total lead time.
Worked Example: Processing Time Versus Waiting Time
Assume one batch moves through the sequential stages below. All figures are elapsed hours on the same clock. This simplified timeline supports a map; it is not a complete value stream map or a benchmark for your plant.
| Stage | Processing or required activity | Waiting before stage |
|---|---|---|
| Material preparation | 2 hours | 8 hours |
| Reaction and required hold | 10 hours | 4 hours |
| Finishing | 3 hours | 6 hours |
| Quality testing | 4 hours | 12 hours |
| Review and dispatch preparation | 1 hour | 10 hours |
| Total | 20 hours | 40 hours |
Total lead time is 60 hours: 20 hours of activities plus 40 hours of waiting. Activity time is not automatically value adding. The next step is to understand the reasons for the queues, especially the 12 hours before testing and 10 hours before review and dispatch.
If a controlled trial reduces those two queues by four hours each, the proposed lead time becomes 52 hours. That eight hour reduction is a planning target, not a guaranteed outcome. Confirm that the changes preserve required checks and do not create a new queue elsewhere.
Turn the Map into a Focused Improvement Plan
Prioritize the constraint affecting delivery rather than the easiest task to shorten. A faster finishing step may simply produce more material waiting for testing. Each proposed action should name an owner, a completion date, the approval needed, and a measure of success.
- For material shortages, review availability checks and supplier delivery information.
- For equipment queues, compare product sequencing, maintenance, and changeover losses.
- For testing delays, assess sample timing, analyst coverage, instrument availability, and document completeness.
- For review queues, clarify responsibilities and escalation rules without bypassing required decisions.
- For dispatch delays, examine packaging availability, warehouse handoffs, and shipment scheduling.
If changeover is the constraint, use our SMED changeover improvement checklist to investigate it in more detail.
Verify the Future State in Practice
Build a realistic future state around the process requirements and available resources. Keep necessary reaction holds, cleaning, sampling, testing, and release decisions in the plan. Use the site’s change review process where applicable and trial changes on comparable work.
Track delivery performance, lead time and its range, queue time, rework, and inventory. Review the result with the people doing the work. Update the map when the product mix, equipment, staffing, or customer requirements change.
Frequently Asked Questions
How is this different from a process flowchart?
A flowchart shows steps. A value stream map also shows the material queues, information flows, and timing that explain overall delivery performance.
Do we need special software?
A whiteboard and a structured data sheet can support the first assessment. Reliable observations matter more than the drawing tool.
Can quality testing be treated as waste?
Required controls remain part of the process. Investigate avoidable waiting, repeat work, and missing information around those controls.
Get Help Assessing Manufacturing Flow
PharmExcel supports manufacturing leaders with practical assessments of bottlenecks, systems, staffing, and operational handoffs. Contact Rob to discuss a manufacturing flow assessment or explore our consulting services.
About the Author
Rob Braddock is the founder of PharmExcel Consulting, former COO of Evergreen Theragnostics, and former Executive Director of Manufacturing Operations at BioCentriq. His career includes manufacturing leadership roles at Pfizer/Wyeth Vaccines and Chemtrade. Learn more about PharmExcel.